Cue Biopharma, Inc. - stock earnings

CUE Quarterly earnings

DateEarningsRevenue
2023Q3 -11.0 million USD 2.1 million USD
2023Q2 -13.2 million USD 1.4 million USD
2023Q1 -13.2 million USD 187000 USD
2022Q4 -14.5 million USD 151227 USD
2022Q3 -10.9 million USD 68000 USD
2022Q2 -13.3 million USD 26000 USD
2022Q1 -14.3 million USD 1.0 million USD
2021Q4 -8.4 million USD 8.3 million USD
2021Q3 -13.0 million USD 2.4 million USD
2021Q2 -10.3 million USD 2.7 million USD
2021Q1 -12.5 million USD 1.6 million USD
2020Q4 -11.1 million USD 475325 USD
2020Q3 -10.0 million USD 704000 USD
2020Q2 -10.8 million USD 1.1 million USD
2020Q1 -12.8 million USD 900000 USD
2019Q4 -8.9 million USD 1.0 million USD
2019Q3 -7.0 million USD 984000 USD
2019Q2 -9.5 million USD 1.1 million USD
2019Q1 -11.3 million USD 370000 USD
2018Q4 -11.6 million USD 330604 USD
2018Q3 -12.6 million USD 449000 USD
2018Q2 -7.3 million USD 172000 USD
2018Q1 -7.5 million USD 191000 USD
2017Q4 -10.4 million USD ? USD
2017Q3 -5.0 million USD ? USD
2017Q2 -4.4 million USD ? USD
2017Q1 -3.4 million USD ? USD
2016Q4 -2.8 million USD ? USD
2016Q3 -2.0 million USD ? USD
2015Q4 -1.9 million USD ? USD

CUE Yearly earnings

DateEarningsRevenue
2023 -51.9 million USD 3.8 million USD
2022 -52.8 million USD 1.2 million USD
2021 -44.2 million USD 14.9 million USD
2020 -44.8 million USD 3.2 million USD
2019 -36.7 million USD 3.5 million USD
2018 -39.0 million USD 1.1 million USD
2017 -23.2 million USD ? USD
2016 -7.7 million USD ? USD
2015 -1.9 million USD ? USD

CUE

Price: $2.13

52 week price:
1.37
5.12

Earnings Per Share: -1.11 USD

P/E Ratio: -1.89

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 255300

Market Capitalization: 85.1 million

Links: